BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 17312290)

  • 1. Pulse pressure and risk of new-onset atrial fibrillation.
    Mitchell GF; Vasan RS; Keyes MJ; Parise H; Wang TJ; Larson MG; D'Agostino RB; Kannel WB; Levy D; Benjamin EJ
    JAMA; 2007 Feb; 297(7):709-15. PubMed ID: 17312290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and the risk of new-onset atrial fibrillation.
    Wang TJ; Parise H; Levy D; D'Agostino RB; Wolf PA; Vasan RS; Benjamin EJ
    JAMA; 2004 Nov; 292(20):2471-7. PubMed ID: 15562125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relations of Arterial Stiffness and Brachial Flow-Mediated Dilation With New-Onset Atrial Fibrillation: The Framingham Heart Study.
    Shaikh AY; Wang N; Yin X; Larson MG; Vasan RS; Hamburg NM; Magnani JW; Ellinor PT; Lubitz SA; Mitchell GF; Benjamin EJ; McManus DD
    Hypertension; 2016 Sep; 68(3):590-6. PubMed ID: 27456517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study.
    Haider AW; Larson MG; Franklin SS; Levy D;
    Ann Intern Med; 2003 Jan; 138(1):10-6. PubMed ID: 12513039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.
    Kannel WB; Wolf PA; Benjamin EJ; Levy D
    Am J Cardiol; 1998 Oct; 82(8A):2N-9N. PubMed ID: 9809895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension.
    Okin PM; Wachtell K; Devereux RB; Harris KE; Jern S; Kjeldsen SE; Julius S; Lindholm LH; Nieminen MS; Edelman JM; Hille DA; Dahlöf B
    JAMA; 2006 Sep; 296(10):1242-8. PubMed ID: 16968848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifiable Risk Factors for Incident Heart Failure in Atrial Fibrillation.
    Chatterjee NA; Chae CU; Kim E; Moorthy MV; Conen D; Sandhu RK; Cook NR; Lee IM; Albert CM
    JACC Heart Fail; 2017 Aug; 5(8):552-560. PubMed ID: 28624486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White blood cell count and risk of incident atrial fibrillation (from the Framingham Heart Study).
    Rienstra M; Sun JX; Magnani JW; Sinner MF; Lubitz SA; Sullivan LM; Ellinor PT; Benjamin EJ
    Am J Cardiol; 2012 Feb; 109(4):533-7. PubMed ID: 22100030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
    Wachtell K; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Nieminen MS; Olsen MH; Okin PM; Palmieri V; Rokkedal JE; Devereux RB
    Blood Press; 2010 Jun; 19(3):169-75. PubMed ID: 20438307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women.
    Conen D; Tedrow UB; Koplan BA; Glynn RJ; Buring JE; Albert CM
    Circulation; 2009 Apr; 119(16):2146-52. PubMed ID: 19364977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment for incident heart failure in individuals with atrial fibrillation.
    Schnabel RB; Rienstra M; Sullivan LM; Sun JX; Moser CB; Levy D; Pencina MJ; Fontes JD; Magnani JW; McManus DD; Lubitz SA; Tadros TM; Wang TJ; Ellinor PT; Vasan RS; Benjamin EJ
    Eur J Heart Fail; 2013 Aug; 15(8):843-9. PubMed ID: 23594831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation and the risk of myocardial infarction.
    Soliman EZ; Safford MM; Muntner P; Khodneva Y; Dawood FZ; Zakai NA; Thacker EL; Judd S; Howard VJ; Howard G; Herrington DM; Cushman M
    JAMA Intern Med; 2014 Jan; 174(1):107-14. PubMed ID: 24190540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and Implications of Atrial Fibrillation/Flutter in Hypertension: Insights From the SPRINT Trial.
    Parcha V; Patel N; Kalra R; Kim J; Gutiérrez OM; Arora G; Arora P
    Hypertension; 2020 Jun; 75(6):1483-1490. PubMed ID: 32362231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of Orthostatic Hypotension With New-Onset Atrial Fibrillation (From the Framingham Heart Study).
    Ko D; Preis SR; Lubitz SA; McManus DD; Vasan RS; Hamburg NM; Benjamin EJ; Mitchell GF
    Am J Cardiol; 2018 Mar; 121(5):596-601. PubMed ID: 29290367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study.
    Vaziri SM; Larson MG; Benjamin EJ; Levy D
    Circulation; 1994 Feb; 89(2):724-30. PubMed ID: 8313561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Risk of Heart Failure and Atrial Fibrillation.
    Kaneko H; Yano Y; Itoh H; Morita K; Kiriyama H; Kamon T; Fujiu K; Michihata N; Jo T; Takeda N; Morita H; Node K; Carey RM; Lima JAC; Oparil S; Yasunaga H; Komuro I
    Circulation; 2021 Jun; 143(23):2244-2253. PubMed ID: 33886370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial differences in incident atrial fibrillation among hypertensive patients during antihypertensive therapy.
    Okin PM; Bang CN; Wachtell K; Hille DA; Kjeldsen SE; Julius S; Dahlöf B; Devereux RB
    Am J Hypertens; 2014 Jul; 27(7):966-72. PubMed ID: 24552888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint (LIFE) reduction in hypertension study.
    Larstorp AC; Ariansen I; Gjesdal K; Olsen MH; Ibsen H; Devereux RB; Okin PM; Dahlöf B; Kjeldsen SE; Wachtell K
    Hypertension; 2012 Aug; 60(2):347-53. PubMed ID: 22753219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P wave duration and risk of longitudinal atrial fibrillation in persons ≥ 60 years old (from the Framingham Heart Study).
    Magnani JW; Johnson VM; Sullivan LM; Gorodeski EZ; Schnabel RB; Lubitz SA; Levy D; Ellinor PT; Benjamin EJ
    Am J Cardiol; 2011 Mar; 107(6):917-921.e1. PubMed ID: 21255761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.